KOTRA (0002) Stock Price, News, Quotes-Moomoo

MY Stock MarketDetailed Quotes

0002 KOTRA

Watchlist

4.620
+0.060+1.32%

15min DelayMarket Closed Dec 13 16:42 CST

685.21MMarket Cap16.86P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Hospital Stocks Broadly Lower After PM Says Will Speed up Plan for Standardised Prices
The Edge MarketsDec 11 01:57 ET
Healthy Demand, Capacity Growth to Drive Healthcare Earnings Through 2025 — Analysts
The Edge MarketsDec 9 00:23 ET
MOT To Continue Flight Ticket Subsidy For Festive Seasons
BernamaDec 5 10:15 ET
KLK Advances 70 Sen, Panasonic Loses 32 Sen
Business TodayDec 2 05:14 ET
Foreign Investors Sold Equities For 4 Consecutive Week
Business TodayDec 1 21:19 ET
KOTRA To Go Ex-Dividend On December 16th, 2024 With 0.125 MYR Dividend Per Share
Moomoo NewsNov 27 16:35 ET

Comments

Adrain teh

Aug 19 20:10

$KOTRA (0002.MY)$ lets fly

Moomoo News MY

May 20 19:35

Columns MY Morning Wrap | Public Bank Reports 3.5% Drop in Net Profit for Q1FY2024

Good morning mooers! Here are things you need to know about today's market:
●Nasdaq and S&P 500 Reach Record Highs Ahead of Nvidia Earnings
●Bursa Malaysia Launches Trading Reminders Tool to Highlight Unusual Trading Activity
●Retail Investors in Malaysia Continue to Sell Local Equities Despite Foreign Interest
●Stocks to watch: Public Bank, KLK
-moomoo News MY
Wall Street Summary
On Monday, the $Nasdaq Composite Index (.IXIC.US)$ and the ...

Moomoo AI

Feb 25 19:27

RHB Research sees potential in Kotra's capacity-driven growth and nutraceutical focus, despite H1 FY24 earnings falling short. CGS-CIMB Research predicts a profit recovery in FY25 and FY26 after a FY24 dip, acknowledging risks like higher input costs and increased ad spend.

Rising Health Awareness to Fuel Kotra's Growth

Moomoo AI

Jan 25 14:56

CGS-CIMB Research predicts Kotra's ROE to remain steady at around 18% in FY25-FY26 due to improved economies of scale. They also forecast a 3% annual rise in local pharmaceutical product revenue and a 6-8% increase in export revenue in FY24-FY26.

Kotra's Long-term ROE Expected to Hold Steady

Heat List

Overall

No Data